Thus phosphorylation and inhibition of TCTP by insulin may serve as potential targets for therapeutic interventions to mitigate TCTP-related diseases and conditions that might include vascular hyperreactivity, sodium pump dysregulation, hypertension, and diabetes mellitus. Here, TPT1 is linked to hypertensive disorder.